Polpharma API

Polpharma API

Produkcja wyrobów farmaceutycznych

Starogard Gdański, pomorskie 7498 obserwujących

FDA-approved European manufacturer of Active Pharmaceutical Ingredients, delivering high-quality products worldwide

Informacje

Polpharma API is a part of Polish leading multinational pharmaceutical group trusted by millions of patients and business partners for over 85 years. Polpharma API CDMO. Thanks to over 70 years of experience in process development, scale-up and cGMP manufacturing, we support both emerging and established pharmaceutical customers in development and commercialization of their small molecule API clinical candidates. At our FDA-approved plant located in Central Europe we provide end-to-end solutions from API development to scale-up allowing smooth process transfer for a commercial scale manufacturing capabilities, with a world-class regulatory support. Our strong R&D management team, experienced in development of chemical processes and complex projects, provides a wide range of solutions to our customers, applying variety of chemical reactions and conditions, including cryogenic, High Pressure, strong base reactions and tailor-made particle size distribution modifications. At Polpharma quality comes first. Regular FDA audits proves our reliability and credibility towards business partners around the world. Our team of highly qualified, skilled and enthusiastic experts combined with state-of-the-art equipment and facilities provides our partners with an outstanding customer experience. Polpharma API. Your European CDMO Partner.

Branża
Produkcja wyrobów farmaceutycznych
Wielkość firmy
1 001-5 000 pracowników
Siedziba główna
Starogard Gdański, pomorskie
Specjalizacje
Pharma, Pharmaceuticals, API's and drug products manufacturer, Active Pharmaceutical Ingredients, CM, Contract Manufacturing, Licensing out and supply, FDF, Finished dosage form, CDMO, European partner, out-licensing, B2B partner i API drug

Aktualizacje

  • Getting ready for a workshop by embracing the fusion of art and technology. At #PolpharmaAPI, we believe in the power of creativity and innovation. We are merging these passions through the #DaliArtBoxExperience show at Warsaw Norblin Factory getting ready for Sales & Project Management Workshop. Inspired by the surreal genius of #SalvadorDali, our team is exploring new dimensions of creativity. This immersive experience allows us to think outside the box, challenge conventional boundaries, and bring a touch of surrealism to our daily jobs. The synergy between art and technology is not only fueling our creativity but also empowers us to approach challenges with a fresh perspective. We’re excited to continue pushing the boundaries and driving innovation in everything we do! #ArtMeetsTech #Innovation #SalesManagement #ProjectManagement #CreativityUnleashed #DaliArtBox #TechInspiration

  • Carbon Footprint Calculation at Polpharma In 2023, we conducted our first calculation of the carbon footprint for products manufactured by Polpharma, following the GHG Protocol Product Life Cycle Accounting and Reporting Standard. The assessment covered 10 of our APIs, including: aniracetam, baclofen, etodolac and ticagrelor. This analysis encompassed emissions from the extraction of raw materials to the manufacturing of the finished products, taking into account emissions released into the environment. In 2024, we calculated the carbon footprint for the next batch of 10 products, including fenyl salicylate, tadalafil, and salicylamide. Thanks to the calculation, we know which stages of the product lifecycle need to be optimized and what we have to do to achieve it.   #carbonfootprint #polpharmaAPI #ProductLifeCycle

  • Zobacz stronę organizacji użytkownika Polpharma API; grafika

    7498 obserwujących

    Cheers to a year of fantastic achievements! And thank you for being part of our journey! As we approach the end of the year, let's take a moment to reflect on the journey behind us. This year has been full of twists and turns, surprises and great achievements. It has been a pleasure to navigate it together, and that's something truly remarkable.   Despite the distances, time zones, and cultural differences, we've built a strong and long-lasting relation with our customers and business partners. We've had some incredible moments, faced challenges, and achieved significant milestones. Our fantastic API team, with their passion and commitment, has been at the heart of this journey. As we look forward to the New Year, we're excited about the new opportunities it will bring. We can't wait to embark on this next chapter together with you. Here's to the year that’s been and the exciting one ahead. May it bring you joy, peace, and everything you hope for. Thank you for being part of our journey. Take care and see you in the New Year!

  • Polpharma API ponownie to opublikował(a)

    Zobacz profil użytkownika Bartosz Bialek; grafika

    Leading product design at Netguru. I can help you ship outstanding digital products on time, with limited risk. Check our work behance.net/netguru dribble.com/netguru. I make puzzle games in free time. Always curious!

    There’s no one-size-fits-all for designing a great website, but we’ve found the perfect combo: user-centric design + the right tools. That’s why I’m thrilled to announce our official status as Webflow Premium Partners! Take Polpharma API, Poland’s largest pharmaceutical manufacturer, for instance. Here’s what we achieved together: - 100 performance score: Fast, stable, and fully responsive - Nearly 2x more inquiries: The redesigned website boosted leads and engagement - Lower bounce rate, higher satisfaction: Plus, cost-efficiency thanks to Webflow Huge thanks to our client Polpharma API! Curious about how Webflow can work for your business? Let us show you the ropes!

    • Brak alternatywnego opisu tekstowego dla tego zdjęcia
  • 𝗘𝗻𝗲𝗿𝗴𝘆   Polpharma Group's operations in Poland require significant heat and electricity for manufacturing processes. To ensure a reliable energy supply, we established an Energy Committee and appointed an Energy Strategy Advisor to create an Energy Master Plan that prioritizes green energy and aligns with our Sustainability Strategy, resulting in exemptions from power supply restrictions for critical plants.    In response to rising energy costs, we implemented smarter purchasing strategies, including:  - Optimizing energy purchases on the Polish Power Exchange (TGE)  - Anticipatory natural gas purchases  - Exploring green energy options through Power Purchase Agreements (PPAs)    We diversified our energy sources by switching to a lower-emission electricity supplier and operating a 2.4 MWp photovoltaic farm in Starogard Gdański, contributing 8% of the plant's energy demand. Additionally, we launched seven photovoltaic micro-installations.    Our Energy-Saving Programme (ESP) has saved about 10,000 MWh of electricity and 52,000 GJ of heat over the past five years. In 2023, we saved approximately 3,645 MWh of electricity and 17,494 GJ of heat, reducing our carbon footprint. Key savings initiatives included upgrading lighting systems, optimizing power contracts, and enhancing energy recovery systems.    These efforts are crucial to our commitment to sustainability and effective energy management. #energymanagement #ESG #Sustanability #EnergySaving 

  • 𝗘𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁𝗮𝗹 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗮𝘁 𝗣𝗼𝗹𝗽𝗵𝗮𝗿𝗺𝗮  At Polpharma, we are dedicated to minimizing the impact of our processes and products on the climate and environment across all stages of operations. Our commitment to environmental responsibility is reflected in our governance and objectives, which include: • 𝗖𝗹𝗶𝗺𝗮𝘁𝗲 𝗮𝗻𝗱 𝗘𝗺𝗶𝘀𝘀𝗶𝗼𝗻𝘀: We aim to reduce GHG emissions (CO2 equivalent) by 17% by 2025 in Scopes 1 and 2 (relative to 2021). • 𝗘𝗻𝗲𝗿𝗴𝘆: Implementing energy-efficient practices to lower our carbon footprint. • 𝗪𝗮𝘁𝗲𝗿, 𝗘𝗳𝗳𝗹𝘂𝗲𝗻𝘁𝘀, 𝗮𝗻𝗱 𝗪𝗮𝘀𝘁𝗲: Conserving water and reducing waste from production processes by 5% until 2025 (relative to 2021). • 𝗠𝗮𝘁𝗲𝗿𝗶𝗮𝗹𝘀 𝗮𝗻𝗱 𝗜𝗻𝗽𝘂𝘁 𝗠𝗮𝘁𝗲𝗿𝗶𝗮𝗹𝘀: Adopting ecodesign standards for the development of new substances and drugs. Our environmental management system is compliant with ISO 14001 and ISO 45001 standards, ensuring that we maintain high standards of environmental and occupational health and safety management. In 2023, we conducted 41 internal system audits to ensure compliance and continuous improvement. Additionally, we have undergone an assessment via the CDP rating platform, receiving a ‘C’ rating, which reflects our commitment to transparency and environmental management. #Sustainability #EnvironmentalResponsibility #PolpharmaGroup #ClimateAction #Ecodesign #GreenInitiatives

  • Sustainable development is essential for ensuring that the needs of the present generation are met without compromising the ability of future generations to meet their own needs. This concept was first introduced in the groundbreaking 1987 UN report “Our Common Future” and emphasizes the importance of balancing economic growth, environmental protection, and social equity. At Polpharma, we are deeply committed to our Sustainable Development Strategy, which covers five focus areas: 1. Access to Health: Ensuring that our products and services are accessible to everyone, promoting health and well-being. 2. Ethical Business Processes: Upholding the highest ethical standards in all our activities. 3. Environmental Impact: Minimizing our environmental footprint through innovative practices and sustainable resource management. 4. Responsible Employer: Fostering a supportive and inclusive workplace for all our employees. 5. Innovation in Action: Continuously seeking innovative solutions to enhance our sustainability efforts. Our primary concentration involves the six key Global Goals for Sustainable Development. By incorporating these pivotal principles into our business approach, we believe we are contributing significantly towards creating a superior world for everyone. We take immense pride in having elevated our #EcoVadis score by five points in 2024, a testament to our unwavering commitment to constant enhancement and transparency. For more details, we invite you to read the Polpharma Sustainable Development Report on our website: https://lnkd.in/evRjFWq4    #SustainableDevelopment #ESG #Polpharma #HealthyLife #Innovation #EcoVadis #Sustainability

  • Zobacz stronę organizacji użytkownika Polpharma API; grafika

    7498 obserwujących

    #Type2Diabetes, a chronic condition impacting millions each year. At Polpharma API our mission is to ensure the availability of high-quality pharmaceutical ingredients for the treatment of diabetes world-wide. #Dapagliflozin, is commonly used in #Type2Diabetes management, due tu: - Effective blood sugar control - Cardiovascular benefits - Kidney health benefits - Positive weight loss impact Check out our wide diabetes portfolio https://lnkd.in/eS6ZxJYf Contact us: api@polpharma.com

  • Zobacz stronę organizacji użytkownika Polpharma API; grafika

    7498 obserwujących

    At #PolpharmaAPI, we are dedicated to supporting the global battle against #Type2Diabetes, a chronic disease impacting millions each year. Our mission is to ensure reliable access to high-quality pharmaceutical ingredients. Our Commitment Extensive Diabetes Portfolio: We offer a comprehensive range of diabetes APIs, backed by international registration documentation to support drug manufacturers worldwide. Quality and Excellence: We are committed to #excellence, contributing to the health and well-being of communities globally. 🌍 Why Empagliflozin? Empagliflozin is a key component in managing type 2 diabetes, helping to lower blood sugar levels and reduce the risk of cardiovascular events. By providing high-quality empagliflozin, we aim to enhance the effectiveness of diabetes treatments and improve patient outcomes. Check out our wide diabetes portfolio Empagliflozin copy At #PolpharmaAPI, we are dedicated to supporting the global battle against #Type2Diabetes, a chronic disease impacting millions each year. Our mission is to ensure reliable access to high-quality pharmaceutical ingredients. Our Commitment Extensive Diabetes Portfolio: We offer a comprehensive range of diabetes APIs, backed by international registration documentation to support drug manufacturers worldwide. Quality and Excellence: We are committed to #excellence, contributing to the health and well-being of communities globally. 🌍 Why Empagliflozin? Empagliflozin is a key component in managing type 2 diabetes, helping to lower blood sugar levels and reduce the risk of cardiovascular events. By providing high-quality empagliflozin, we aim to enhance the effectiveness of diabetes treatments and improve patient outcomes. Check out our wide diabetes portfolio https://lnkd.in/eS6ZxJYf Contact us: api@polpharma.com #Empagliflozin #diabetes #highquality #diabetestreatments #Type2Diabetes #Polpharma

  • More Than Just a Mustache This November, let’s go beyond the mustache and dive into the heart of what #Movember truly stands for a commitment to improving men’s health in all its facets. Movember is about raising awareness and encouraging men to take charge of their physical and mental health. Men’s mental health is a critical issue that often goes unspoken. Many men struggle with opening up about their mental well-being due to societal pressures and stigma. Movember aims to break these barriers by promoting open conversations and supporting those in need. It’s a reminder that seeking help is a sign of strength, not weakness. Movember encourages men to prioritize their health by scheduling routine screenings, adopting a balanced diet, exercising regularly, and avoiding harmful habits like smoking. These small steps can make a significant difference in overall well-being. By being proactive and well-informed, men can greatly reduce their risk of serious health problems. #Movember #MensHealth #MentalHealth #HealthyLiving 

Powiązane strony

Podobne strony